Steutel Nina F, Benninga Marc A, Langendam Miranda W, Korterink Judith J, Indrio Flavia, Szajewska Hania, Tabbers Merit M
Department of Paediatric Gastroenterology and Nutrition, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands.
Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre, Amsterdam, The Netherlands.
BMJ Open. 2017 May 29;7(5):e015418. doi: 10.1136/bmjopen-2016-015418.
Infant colic (IC) is defined as recurrent and prolonged crying without an obvious cause or evidence of failure to thrive or illness. It is a common problem with a prevalence of 5%-25%. The unknown aetiology results in a wide variety in interventions and use of heterogeneous outcome measures across therapeutic trials. Our aim was to develop a core outcome set (COS) for IC to facilitate and improve evidence synthesis.
Prospective study design; primary, secondary and tertiary care.
The COS was developed using a modified Delphi technique. First, healthcare professionals (HCPs) and parents of infants with IC were asked to list up to five outcomes they considered relevant in the treatment of IC. Outcomes mentioned by >10% of participants were forwarded to a shortlist. In the second round, outcomes on this shortlist were rated and prioritised. The final COS was defined in a face-to-face expert meeting of paediatricians.
F of invited stakeholders (133 HCPs and 55 parents of infants with IC) completed both Delphi rounds. Duration of crying, family stress, sleeping time of infant, quality of life (of family), discomfort of infant and hospital admission/duration were rated as most important outcomes in IC, framing the final COS.
The use of this COS should serve as a minimum of outcomes to be measured and reported. This will benefit evidence synthesis, by enhancing homogeneity of outcomes, and enable evaluation of success in therapeutic trials on IC. Researchers are strongly encouraged to use this COS when setting up a clinical trial in primary, secondary and/or tertiary care or performing a systematic review on IC.
婴儿腹绞痛(IC)被定义为反复且长时间哭闹,无明显病因,也无发育不良或患病的证据。这是一个常见问题,患病率为5%-25%。病因不明导致干预措施种类繁多,且不同治疗试验使用的结局指标各异。我们的目的是制定一套婴儿腹绞痛的核心结局指标集(COS),以促进和改进证据综合。
前瞻性研究设计;一级、二级和三级医疗保健机构。
采用改良德尔菲技术制定COS。首先,要求医疗保健专业人员(HCPs)和患有婴儿腹绞痛的婴儿家长列出他们认为在婴儿腹绞痛治疗中相关的最多五个结局指标。超过10%的参与者提及的结局指标被列入候选清单。在第二轮中,对候选清单上的结局指标进行评分和排序。最终的COS在儿科医生的面对面专家会议上确定。
受邀的利益相关者(133名HCPs和55名患有婴儿腹绞痛的婴儿家长)完成了两轮德尔菲调查。哭闹持续时间、家庭压力、婴儿睡眠时间、(家庭的)生活质量、婴儿不适以及住院情况/住院时间被评为婴儿腹绞痛最重要的结局指标,构成了最终的COS。
使用这套COS应作为测量和报告的最少结局指标。这将通过提高结局指标的同质性来促进证据综合,并有助于评估婴儿腹绞痛治疗试验的成功与否。强烈鼓励研究人员在一级、二级和/或三级医疗保健机构开展临床试验或对婴儿腹绞痛进行系统评价时使用这套COS。